GlobeNewswire 2012-08-13 Pharming updates on ongoing call of first tranche of €10 million equity working capital facility and...
GlobeNewswire 2012-08-10 Pharming updates on ongoing call of first tranche of €10 million equity working capital facility
GlobeNewswire 2012-08-09 Pharming updates on ongoing call of first tranche of €10 million equity working capital facility
GlobeNewswire 2012-08-08 Pharming draws first tranche under €10 million working capital facility
GlobeNewswire 2012-08-02 Pharming announces restructuring plan
GlobeNewswire 2012-08-01 Pharming secures €10 million working capital facility from existing investors
GlobeNewswire 2012-07-16 Pharming confirms safety profile of recombinant human Lactoferrin in a food safety study in healthy ...
GlobeNewswire 2012-07-05 Pharming completes recruitment of RUCONEST® US pivotal Phase III study
GlobeNewswire 2012-07-03 Pharming announces sale of US facilities
GlobeNewswire 2012-07-02 Pharming Group N.V.: New data published on RUCONEST's protective effects after severe blood loss
GlobeNewswire 2012-06-25 Pharming focuses on transgenic rabbit platform closure of US based cattle platform operations
GlobeNewswire 2012-06-19 Pharming provides management update
GlobeNewswire 2012-06-18 Pharming announces presentation of new Ruconest® clinical data
GlobeNewswire 2012-06-15 Pharming updates on study 1310 and shares in issue
GlobeNewswire 2012-06-13 Pharming redeems final tranche of convertible bond
GlobeNewswire 2012-06-12 PHARMING UNDERTAKES REVIEW OF STRATEGIC OPTIONS
GlobeNewswire 2012-04-26 Pharming reports financial results first quarter 2012
GlobeNewswire 2012-03-26 Pharming and Hyupjin Corporation announce commercialisation agreement for RUCONEST in Korea
GlobeNewswire 2012-03-01 Pharming announces preliminary financial results 2011
GlobeNewswire 2012-02-14 Pharming and Transmedic announce distribution agreement for RUCONEST
GlobeNewswire 2012-01-06 Pharming redeems part of convertible bond
GlobeNewswire 2011-12-16 Pharming announces agreement with Renova Life targeting factor VIII for the treatment of haemophilia...
GlobeNewswire 2011-12-12 Pharming granted U.S. patent on C1 inhibitor use in ischemia reperfusion injury indications
GlobeNewswire 2011-12-09 Pharming reports on negative equity position as a result of compliance with IFRS
GlobeNewswire 2011-12-07 Santarus and Pharming announce oral presentations of retrospective analyses of data from RHUCIN clin...